These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38619853)

  • 21. Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain Atrophy in Patients With Alzheimer Disease and Seizures.
    Lam AD; Thibault EG; Mayblyum DV; Hsieh S; Pellerin KR; Sternberg EJ; Viswanathan A; Buss S; Sarkis RA; Jacobs HIL; Johnson KA; Sperling RA
    Neurology; 2024 Nov; 103(9):e209920. PubMed ID: 39331846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease.
    Guo T; Li A; Sun P; He Z; Cai Y; Lan G; Liu L; Li J; Yang J; Zhu Y; Zhao R; Chen X; Shi D; Liu Z; Wang Q; Xu L; Zhou L; Ran P; Wang X; Sun K; Lu J; Han Y
    Mol Neurodegener; 2024 Jul; 19(1):58. PubMed ID: 39080744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
    Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC
    JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
    Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
    Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
    Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
    JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
    Moloney CM; Labuzan SA; Crook JE; Siddiqui H; Castanedes-Casey M; Lachner C; Petersen RC; Duara R; Graff-Radford NR; Dickson DW; Mielke MM; Murray ME
    Alzheimers Dement; 2023 Mar; 19(3):1029-1040. PubMed ID: 35920592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
    Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O
    JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
    J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging.
    Doering S; McCullough A; Gordon BA; Chen CD; McKay N; Hobbs D; Keefe S; Flores S; Scott J; Smith H; Jarman S; Jackson K; Hornbeck RC; Ances BM; Xiong C; Aschenbrenner AJ; Hassenstab J; Cruchaga C; Daniels A; Bateman RJ; ; Morris JC; Benzinger TLS
    EBioMedicine; 2024 May; 103():105080. PubMed ID: 38552342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy.
    Mantyh WG; Spina S; Lee A; Iaccarino L; Soleimani-Meigooni D; Tsoy E; Mellinger TJ; Grant H; Vandevrede L; La Joie R; Lesman-Segev O; Gaus S; Possin KL; Grinberg LT; Miller BL; Seeley WW; Rabinovici GD
    JAMA Neurol; 2020 Apr; 77(4):517-521. PubMed ID: 31904765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer's disease: A cross-sectional study.
    Matchett BJ; Lincoln SJ; Baker M; Tamvaka N; Labuzan SA; Hicks Sirmans TN; Moloney CM; Helminger J; Hinkle KM; Cabrera-Rodriguez J; Wickland DP; Johnson PW; Heckman MG; Reddy JS; Younkin SG; Carrasquillo MM; Duara R; Graff-Radford NR; Pottier C; Ertekin-Taner N; Ross OA; Rademakers R; Dickson DW; Murray ME
    Medicine (Baltimore); 2023 Jun; 102(24):e34017. PubMed ID: 37327267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    Nihashi T; Sakurai K; Kato T; Iwata K; Kimura Y; Ikenuma H; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Suzuki K; Bundo M; Sakurai T; Okamura N; Yanai K; Ito K; Nakamura A;
    J Alzheimers Dis; 2022; 85(1):223-234. PubMed ID: 34776443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.
    Martersteck A; Ayala I; Ohm DT; Spencer C; Coventry C; Weintraub S; Bigio EH; Mesulam M-; Geula C; Rogalski E
    Acta Neuropathol Commun; 2022 Aug; 10(1):111. PubMed ID: 35945628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.
    Alosco ML; Su Y; Stein TD; Protas H; Cherry JD; Adler CH; Balcer LJ; Bernick C; Pulukuri SV; Abdolmohammadi B; Coleman MJ; Palmisano JN; Tripodis Y; Mez J; Rabinovici GD; Marek KL; Beach TG; Johnson KA; Huber BR; Koerte I; Lin AP; Bouix S; Cummings JL; Shenton ME; Reiman EM; McKee AC; Stern RA;
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):435-452. PubMed ID: 36152064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
    Quesnel MJ; Labonté A; Picard C; Zetterberg H; Blennow K; Brinkmalm A; Villeneuve S; Poirier J; ;
    Brain; 2024 May; 147(5):1680-1695. PubMed ID: 37992295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.
    Janelidze S; Berron D; Smith R; Strandberg O; Proctor NK; Dage JL; Stomrud E; Palmqvist S; Mattsson-Carlgren N; Hansson O
    JAMA Neurol; 2021 Feb; 78(2):149-156. PubMed ID: 33165506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
    Edwards L; La Joie R; Iaccarino L; Strom A; Baker SL; Casaletto KB; Cobigo Y; Grant H; Kim M; Kramer JH; Mellinger TJ; Pham J; Possin KL; Rosen HJ; Soleimani-Meigooni DN; Wolf A; Miller BL; Rabinovici GD
    Neurobiol Aging; 2021 Sep; 105():86-98. PubMed ID: 34049062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.